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Summary 
P-selectin binding to neutrophils requires a specific 
protein, P-selectin glycoprotein ligand 1 (PSGL-l), as 
well as sialyl-Lewis X (sLe”) glycan determinants. We 
have found that a short segment near the amino termi- 
nus of PSGL-1 that contains a tyrosine sulfation con- 
sensus is essential for P-selectin adhesion and that 
addition of the amino-terminal segment to some but 
not all mucin-like molecules confers on those mole- 
cules theabilityto bind P-selectin. PSGL-1 synthesized 
in the presence of sulfation inhibitors binds P-selectin 
weakly, and within the amino-terminal 20 residues, 
mutation of the tyrosines to phenylalanine abolishes 
binding. Rolling of HL-60 cells on P-selectin-coated 
coverslips is strongly attenuated by treatment of cells 
with an inhibitor of sulfation. 
Introduction 
P-selectin is an integral membrane C-type lectin found 
within the Weibel-Palade bodies of endothelial cells 
(McEver et al., 1989; Bonfanti et al., 1989) and the a gran- 
ules of platelets (Hsu-Lin et al., 1984; Stenberg et al., 
1985). Its translocation to the plasma membrane can be 
induced by thrombin (Hsu-Lin et al., 1984; Stenberg et al., 
1985), histamine, and other mediators released by mast 
cell activation (Hattori et al., 1989a; Kubes and Kanwar, 
1994; Thorlacius et al., 1994) complement C5b-9 complex 
or C5a fragment (Hattori et al., 1989b; Foreman et al., 
1994), and peroxides (Pate1 et al., 1991). Once displayed 
on the cell surface, P-selectin supports the attachment of 
myelomonocytes to platelets (Larsen et al., 1989; Ham- 
burger and McEver, 1990) or endothelial cells (Geng et 
al., 1990; Gamble et al., 1990). In the latter setting, its 
appearance heralds an underlying tissue insult and sup- 
ports the initial step in leukocyte extravasation, the rolling 
of neutrophils along the postcapillary venule wall (Law- 
rence and Springer, 1991). Mice homozygously deficient 
for the P-selectin structural gene exhibit deficits in leuko- 
cyte rolling and show delayed recruitment of granulocytes 
to sites of experimentally induced inflammation (Mayadas 
et al., 1993). 
If there is a unifying theme to the pattern of mediators 
that induce P-selectin expression, it is the integration of 
signals that commonly arise in the context of trauma or 
wounding. One of the first recognized responses to tissue 
trauma is mast cell activation, which is accompanied by 
release of histamine, serotonin, and other diffusible medi- 
ators. Although induction of P-selectin-mediated neutro- 
phil rolling has been thought to be an inevitable conse- 
quence of surgical intervention, cromolyn, an agent that 
blocks mast cell degranulation, has been shown to prevent 
such rolling, thereby providing an elegant demonstration 
of the role of the mast cell as the link between trauma and 
extravasation (Kubes and Kanwar, 1994). 
Much is presently known about the residues on P-selectin 
that are important for binding (Hollenbaugh et al., 1993; 
Erbeet al., 1993; Bajorathet al., 1994; Kansaset al., 1994; 
Murphy and McGregor, 1994), but the precise structure 
on human neutrophils that serves as a ligand has proven 
elusive. Soluble human P-selectin chimeras recognize a 
specific homodimeric counterreceptor that bears sialy- 
lated, fucosylated O-linked glycans (Moore et al., 1992, 
1994; Norgard et al., 1993). A cDNA encoding this counter- 
receptor, termed P-selectin glycoprotein ligand 1 (PSGL-1) 
(Sako et al., 1993) was isolated by expression cloning in 
COS cells cotransfected with a fucosyltransferase, FTIII 
(Kukowska-Latallo et al., 1990), known to give rise to Lewis 
X (Le”), sialyCLewis X (sLe”), Lewis A (Lea), and sialyl-Lewis 
A (sLe”) glycans. Thus, reconstitution of the neutrophil 
ligand for P-selectin in COS cells requires at least two 
elements, an enzyme to supply fucose and a specific pro- 
tein backbone (PSGL-1). PSGL-1 has typical features of 
an integral membrane mucin, but appears to be uniquely 
suited for interaction with P-selectin because expression 
of other mucins in COS cells in the presence of the same 
fucosyltransferase does not support P-selectin binding 
(Sako et al., 1993). 
In addition to fucose and PSGL-1, additional compo- 
nents of the P-selectin ligand may be inapparent because 
of their constitutive production in COS cells. For example, 
both sialic acid and sulfate may be necessary for binding. 
Neuraminidase treatment of target cells significantly atten- 
uates binding to P-selectin (Corral et al., 1990; Moore et 
al., 1991) whereas suppression of sulfation on HL-60 cells 
by exposure to sodium selenate has effects of similar po- 
tency (Aruffo et al., 1991). These results raise the possibil- 
ity that both sulfation in some form and the sLeX determi- 
nant are components of the target structure recognized 
by P-selectin. 
Less is known about P-selectin ligands in mice, but a 
160 kDa protein has been identified on neutrophils that 
binds selectively to a murine P-selectin-immunoglobulin 
chimera (Lenter et al., 1994) suggesting that specific pro- 
tein scaffolds may also be required for binding. The murine 
chimera also recognizes some but not all glycoforms of 
a low molecular weight mucin-like molecule called CD24- 
heat stable antigen (Sammar et al., 1994). A correlation 
was found between those isoforms showing P-selectin 
binding and those reacting with an antibody recognizing 
a complex glycan bearing sulfate and glucuronic acid, 
known as HNK-1 (Sammar et al., 1994). 
An important topic that remains to be addressed is the 
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specific sequence features that qualify PSGL-1 as a hu- 
man P-selectin counterreceptor. In thisstudy, we report an 
analysis of the elements of PSGL-1 that support P-selectin 
binding, from which we conclude that avery short element 
in the apical domain of PSGL-1 contains regulatory ele- 
ments, including three sites of potential tyrosine sulfation, 
which are critical for P-selectin ligand function. Treatment 
of transfected COS cells with chlorate, an inhibitor of sul- 
fation (Baeuerle and Huttner, 1986) partially blocks adhe- 
sion to P-selectin but has little effect under the same condi- 
tions on binding to E-selectin. 
Results 
The Amino Terminus of PSGL-1 Is Necessary 
for P-Selectin Binding 
Gross deletions from the amino terminus of the PSGL-1 
mucin were prepared bypolymerasechain reaction (PCR), 
and the resulting truncated cDNAs were inserted down- 
stream from a secretory peptide sequence fused to a pep- 
tide tag derived from influenza hemagglutinin (HA). Ex- 
pression plasmids encoding the truncated molecules 
(Figure 1A) were transfected into COS cells in the pres- 
ence of a myeloid fucosyltransferase, FTVII, which directs 
the expression of sLe” determinants exclusively (Sasaki 
et al., 1994; Natsuka et al., 1994). Measurement of the 
binding of radiolabeled transfected cells to plastic wells 
precoated with P-selectin-immunoglobulin fusion protein 
showed that deletion of the amino-terminal 100 residues 
of PSGL-1 was sufficient to abolish binding (Figure 1B). 
Expression of the deletion variants at the cell surface was 
confirmed by indirect immunofluorescence using anti-HA 
monoclonal antibodies, and the presence of sLeX on the 
cell surface was confirmed using the monoclonal antibody 
CSLEX-1 (Figure 1C). 
The Amino Terminus of PSGL-1 Is Sufficient 
for Binding in the Context of Some 
but Not All Mucins 
To explore whether PSGL-1 sequences other than those 
in the apical domain of PSGL-1 were required for binding, 
the transmembrane and cytoplasmic regions of PSGL-1 
were replaced with those of the CD43 antigen (Pallant et 
al., 1989; Shelley et al., 1989). The resulting molecule, 
which bore no cysteine residues, showed no compromise 
of binding activity (data not shown). Thus, under these 
conditions, neither PSGL-1 disulfide bond formation nor 
a specific membrane-anchoring segment are required for 
P-selectin binding. 
The predicted first 100 amino acidsof PSGL-1 were then 
genetically grafted onto the amino termini or mucin-like 
repeat elements of a small number of unrelated mucins 
to determine whether the PSGL-1 apical domain is suffi- 
cient for P-selectin counterreceptor activity (Figure 2A). 
Some but not all mucins proved capable of supporting 
P-selectin binding in this setting. CD34 and CD43, two 
relatively large mucins found predominantly on human he- 
matopoietic cells, were both capable of supporting bind- 
ing, whereas an artificially anchored variant of glycosyla- 
tion-dependent cell adhesion molecule 1 (GlyCAM-I), a 
PSGL-l-flu 5.0 37 
Xbal 17 26 
Xba3 20 26 
Xba6 21 28 
Xba9 12 26 
XbalP 6.0 30 
Xbal6 6.0 25 
Figure 1. Effect of Amino-Terminal Gross Deletions on PSGL-1 Ac- 
tivity 
(A) Schematic structure of the PSGL-1 deletions. Systematic deletion 
of the ectodomain of PSGL-1 was undertaken by a PCR strategy. A 
representative lo-residue repeat is shown stippled, and the transmem- 
brane domain is hatched. 
(B) P-selectin-binding activity of transfected COS cells expressing the 
deletions shown in (A). 5’Cr-labeled cells were allowed to adhere to 
soluble P-selectin adsorbed to microtiter wells and washed, and the 
bound cells were lysed and counted. Deletion constructs were 
transfected either in the absence (column 2) or presence (remaining 
seven columns) of the human FTVII fucosyltransferase (FTVllh). Error 
bars denote one standard deviation. 
(C) Mean fluorescence intensity (MFI) of COS cells cotransfectecf with 
human FTVllh and the deletion constructs shown in (A) and subjected 
to indirect immunofluorescence with antibody against the amino- 
terminal flu peptide or sLe”. 
mucin expressed on high endothelial venules that has 
L-selectin ligand activity (Lasky et al., 1992) was inactive 
in this assay (Figure 28). The GlyCAM-1 mucin domain 
in these experiments was tethered to the cell surface via 
the extracellular stalk, transmembrane, and cytoplasmic 
anchoring segments of CD7 (Aruffo and Seed, 1987). Cell 
surface expression of the different mucins and mucin chi- 
meras was confirmed by indirect immunofluorescence us- 
ing antibodies against flu tag, sLe”, or the respective mu- 
tins (Figure 2C; data not shown). 
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Figure 2. P-Selectin-Binding Activity of Ghimeric Mucins Bearing the 
PSGL-1 Apical Domain 
(A) Diagram of the constructs. The PSGL-1 N-terminus is stippled, the 
transmembrane domains are shown hatched, and a representative 
repeat is shown densely stippled. The PSGL-1 N-terminus was fused 
to the N-terminus of the predicted mature CD34 and GlyCAM-1 and 
to the N-terminus of the repeat region of CD43. 
(B) P-selectin-binding activity of transfected COS cells expressing ei- 
ther intact mucins, or the amino-terminally derivatized constructs 
shown in (A). Both native and derivatized GlyCAM-1 are tethered to the 
membrane through a CD7 stalk and transmembrane domain. FTVllh, 
human FTVII fucosyltransferase. CDM8, vector control. Error bars de- 
note one standard deviation. 
(C) Mean fluorescence intensity measurement of expression of flu tag 
or sLe” by COS cells transfected with the constructs analyzed in (8). 
CD34 and CD43 constructs were positive for expression by indirect 
immunofluorescence using the cognate anti-CD antibodies (data not 
shown). 
Mucins That Support Apical Domain-Directed 
Binding Are Large and Sulfated 
The apparent molecular masses determined by denatur- 
ing polyacrylamide gel electrophoresis of CD43 and CD34 
expressed in COS cells have been reported to be 100- 
130 kDa (Shelley et al., 1989) and 100 kDa (Simmons et 
al., 1992), respectively, whereas the PSGL-1 monomer 
exhibits an effective molecular mass of 110 kDa (Sako 
et al., 1993). GlyCAM-1, in its native (untethered) state, 
comigrates with 50 kDa proteins (Lasky et al., 1992). Al- 
though it has not been established at present whether a 
precise estimate of the molecular mass of a mucin-like 
protein can be achieved by measurement of relative mobil- 
ity in polyacrylamide gels, nor the appropriate migration- 
mass relationship, the larger mucins appear to be able 
to support P-selectin binding when the apical domain of 
PSGL-1 is appended to the amino terminus. 
To explore the possibility that sulfation might be one 
determinant of the ability of other mucins to support apical 
domain-directed binding, we evaluated the potential of 
the different mucins above to undergo sulfation in COS 
cells. PSGL-1, CD34, CD43, and GlyCAM-1 soluble mucin 
chimeras readily incorporated sodium [%]sulfate when 
expressed in COS cells (Figure 3). 
Sequential deletion of the internal repeat elements of 
PSGL-1 allows one to shorten the molecule in a regular 
and systematic way with relatively little danger of compro- 
mising hypothetical global tertiary associations. As repeat 
elements were deleted, the binding activity of PSGL-1 de- 
clined, consistent with the idea that distance from the 
plasma membrane might be an important determinant of 
P-selectin-binding activity (data not shown). Alternatively, 
other factors, such as carbohydrate density, may contrib- 
ute to P-selectin binding efficacy. 
Inhibition of Sulfation Blocks PSGL-1 Binding 
to P-Selectin 
In previous studies, the sulfation inhibitor sodium selenate 
was found to compromise binding of HL-60 cells to soluble 
P-selectin significantly, while having little or no effect on 
binding of the cells to soluble E-selectin (Aruffo et al., 
1991). Although sodium selenate proved too toxic for use 
in transient expression studies, sodium chlorate, another 
2OOkD + 
ABCDE F 
92.5kD + 
69kD + 
46kD -t 
Figure 3. Mucin Sulfation 
Mucin-immunoglobulin fusion proteins were labeled with [%]sulfate, 
purified on anti-human IgG agarose, and electrophoresed on an 8% 
denaturing polyacrylamide gel under reducing conditions. Shown is 
an autoradiogram of the immunoprecipitates of culture supernatants 
of cells transfected with the following: lane A, CDM8 (vector); lane B, 
immunoglobulin expression vector (no mucin insert); lane C, PSGL-l- 
immunoglobulin; lane D, CD43-immunoglobulin; lane E, CD34-immu- 
noglobulin; lane F, GlyCAM-I-immunoglobulin. 
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relatively selective inhibitor of sulfation (Baeuerle and Hut- 
tner, 1986) was effective. COS cells were cotransfected 
with PSGL-1 and FTVII, or transfected with PSGL-1 and 
FTVII separately, and incubated for the time period during 
which maximum synthesis of PSGL-1 was expected in a 
modified DMEM medium lacking sulfate and containing 
10 mM sodium chlorate. Under these conditions, we ob- 
served a significant decrease in the ability of cotransfected 
cells to bind to immobilized P-selectin, whereas the same 
cells showed little or no decrement in binding to immobi- 
lized E-selectin (Figures 4A and 48). The cell surface ex- 
pression of either the sLex antigen or the PSGL-1 amino- 
terminal tag sequence was not compromised by this 
treatment (Figure 4C). Rather, an increase in the mean 
fluorescence intensity of the transfected cells, for both 
antisle” and anti-flu tag, was observed following chlorate 
treatment. At present, the explanation for this is uncertain. 
A soluble PSGL-1 immunoglobulin chimera synthesized 
under comparable conditions showed essentially com- 
plete inhibition of [%]sulfate incorporation (Figure 4D) un- 
der conditions in which protein synthesis, as measured 
by [35S]cysteine and methionine incorporation, was not 
inhibited (Figure 4E). 
Fine Structure Deletion Analysis of the Apical 
Domain of PSGL-1 
To localize elements of the apical domain that contribute 
to P-selectin counterreceptor activity, we prepared a se- 
ries of finer deletions across the apical domain, again plac- 
ing each amino-terminal deletion downstream from the 
CD5 leader/flu tag element to monitor cell surface expres- 
sion (Figure 5A). Removal of 20 amino acids from the pre- 
dicted mature N-terminus had no effect on P-selectin- 
binding activity, whereas removal of 40 amino acids 
abrogated binding (Figure 5B). As was the case for the 
gross deletions, fine structure deletions showed little vari- 
ability in expression of the epitope tag as assessed by 
indirect immunofluorescence(Figure5C). Furtherdeletion 
gave no change in activity. Thus, sequences between 
amino acid residues 20-40 (residues 38-57 of the pre- 
dicted precursor) appear to be required for P-selectin 
binding. 
Sufficiency of a 20 Amino Acid Peptide Fragment 
for P-Selectin Counterreceptor Activity 
To test whether residues 38-57 are sufficient for PSGL-1 
apical domain-directed activity, we appended this seg- 
ABCD 
E 
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200kD + li:::?!& ../ . . . . . . . 
92.6kD e 
69kD -)- 
46kD e 
Figure 4. Chlorate Inhibits P- but Not ESelec- 
tin-Mediated Adhesion under Conditions That 
Do Not Inhibit Protein Synthesis in General 
(A) Binding of cells to P-selectin, conducted as 
described for Figure 1. 
(B) Binding of cells to E-selectin under the 
same conditions. 
(C) Chlorate does not inhibit surface expres- 
sion of PSGL-1 or sLe”. Shown are the mean 
fluorescence intensitiesof COS cells transfected 
with PSGL-1 with or without FTVII and sub- 
jected to indirect immunofluorescence with an- 
tibody against the amino-terminal influenza HA 
peptide or sLeX. 
(D and E) Chlorate inhibits incorporation of 
[“Slsulfate into soluble mucin chimeras, but 
does not inhibit protein synthesis in general. 
Shown are autoradiograms of PSGL-l-immu- 
noglobulin fusion proteins labeled with [%]suI- 
fate (D) or [“Slcysteine and methionine (E) in 
the presence or absence of IO mM NaC103 and 
electrophoresed on an 8% denaturing poly- 
acrylamide gel under reducing conditions. 
Lane A, supernatant of CDM8 transfected cells 
in the absence of chlorate; lane B, supernatant 
of cellsexpressing PSGL-I-immunoglobulin in 
the absence of chlorate; lane C, supernatant 
of CDM8 in the presence of chlorate; lane D, 
supernatant of cells expressing PSGL-l-immu- 
noglobulin in the presence of chlorate. 
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Figure 5. Sequence and P-Selectin-Binding Activity of Deletion Vari- 
ants of PSGL-1 Lacking Smaller Elements of the Amino-Terminal Api- 
cal Domain 
(A) Sequence of PSGL-1 and deletion endpoints. Numbering corre- 
sponds to residues in the PSGL-1 precursor (Sako et al., 1993). 
(B) P-selectin-binding activity of transfected COS cells expressing the 
deletion variants with endpoints shown in (A). 
(C) Mean fluorescence intensity of COS cells transfected with the dele- 
tion constructs shown in (A) and subjected to indirect immunofluores- 
cence with antibody against the amino-terminal influenza HA peptide. 
ment to the amino termini of apical domain-deleted 
PSGL-1 and CD43 (Figure 6A). In both cases, the addition 
of this short peptide element conferred P-selectin-binding 
activity upon the mucin core that was equivalent to that 
of native PSGL-1 (Figure 6C). 
Specific Residues Required within the 
Amino-Terminal Peptide 
Within the 20 amino acid residues necessary for P-selectin 
binding are three potential tyrosine sulfation sites and two 
threonine residues. The tyrosines and threonines were 
subjected to concerted mutation to phenylalanine or ala- 
nine, respectively, turning all three tyrosines to phenylala- 
nines and both threonines to alanines. In addition, a quin- 
Figure 6. Effect of Appending Wild-Type and Mutant Variants of 
PSGL-1 Residues 38-57 to Deleted PSGL-1 or CD43 
(A) Diagram of the wild-type constructs. 
(B) Sequences and nomenclature of the wild-type and mutant variants 
of PSGL-1 residues 36-57, with the mean fluorescence intensities of 
the cognate transfectants. 
(C) P-selectin-binding activity of transfected COS cells expressing the 
chimeras shown in (A) and(B). PSGL-I form 1 Rl is full-length PSGL-1 
bearing an EcoRl site at the junction of the N-terminal domain and 
the repeat elements. 
(D) Binding of chimeric mucins bearing the amino-terminal 20 residue 
peptide is sensitive to EDTA. 
tuple mutation was prepared in which both conversions 
were made in the same peptide. Each mutated sequence 
was placed in the same sequence context downstream of 
the flu tag and upstream of either truncated PSGL-1 lack- 
ing the apical domain, or the CD43 repeat elements and 
transmembrane domain. Cells expressing the resulting 
chimeras were tested for their ability to bind to immobilized 
P-selectin. Conversion of the tyrosines to phenylalanines 
resulted in a loss of binding activity to P-selectin (Figure 
6C), without compromise of the expression of the flu tag 
or sLex epitope (Figure 68). Replacement of the threonine 
residues with alanine diminished binding, but did not abol- 
ish it entirely (Figure 6C). Binding mediated by the apical 
20 residues was, like that of native PSGL-1, dependent 
on the presence of calcium (Figure 6D). P-selectin binding 
by chimeric mucins bearing the apical 20 amino acid seg- 
ment was inhibitable by chlorate, whereas E-selectin bind- 
ing was unaffected under the same conditions (data not 
shown). 
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Residues within the Amino-Terminal 20 Amino 
Acids Are Sulfated on Tyrosine 
To determine whether the amino-terminal segment was 
capable of being sulfated in vivo, we created fusion pro- 
teins consisting of the native or mutant peptide sequences 
joined to human immunoglobulin Gl (IgGl) (Figure 7A). 
The resulting fusion proteins were expressed in COS cells 
(Figure 78), and their ability to assimilate inorganic sulfate 
was assessed. lmmunoglobulin chimeras bearing the na- 
tive peptide sequences were capable of incorporating sul- 
fate, whereas those bearing phenylalanine substituted for 
tyrosine were not (Figure 7C). Replacement of threonine 
with alanine had no effect on sulfate incorporation (Fig- 
ure 7C). 
Inhibitors of Sulfation Block HL-60 Rolling on 
P-Selectin-lmmunoglobulin Chimeras 
To explore whether inhibition of sulfation would compro- 
mise a physiologically relevant adhesion, we subjected 
HL-60 cells to growth in medium containing chlorate and 
examined the ability of the resulting cells to attach and 
roll on coverslips coated with P-selectin-immunoglobulin 
chimeras under conditions of defined fluid shear stress 
A 
(Lawrence et al., 1990). HL-60 cells were capable of at- 
taching to and rolling upon coverslips precoated with 
P-selectin-immunoglobulin chimera, whereas no such in- 
teractionwasobserved with coverslips coated with aCD4- 
immunoglobulin chimera (Figure 8; data not shown). 
Growth of HL-60 cells in chlorate dramatically reduced the 
frequency of cell interaction with the substrate (Figure 8). 
Discussion 
The selectin family of cell surface lectins mediates the 
initial phase of leukocyte-endothelial adhesion, the rolling 
of cells along activated endothelium (von Andrian et al., 
1991; Lawrence and Springer, 1991). Members of the fam- 
ily share a common facility for the recognition of glycans 
bearing sLeX determinants (Foxall et al., 1992). However, 
there are clear differences in the target recognition pat- 
terns of the different selectins. E-selectin mediates the 
binding of both hematopoietic and nonhematopoietic cells 
bearing sLeX in a large number of different glycan and 
protein scaffold contexts (Lowe et al., 1990; Walz et al., 
1990; Phillips et al., 1990), suggesting that many proteins 
w-r-MgG RDRRQATEYEYLDYDFLPET 
YIF-hlgG RDRRQATEFEFLDFDFLPET 
TIA-h&G RDRRQAAEYEYLDYDFLPEA 
“IF-T/A-hlge RDRRQAAEFEFLDFDFLPEA 
ABCDE F ABCDE FG 
46kD * 46kD -) 
Figure 7. Amino-Terminal Tyrosine Residues 
Are Sulfated In Vivo 
lmmunoglobulin fusion proteins consisting of 
either intact PSGL-1 or 20 residue peptides 
joined to the hinge, CH2, and CH3 domains of 
human IgGl were expressed in COS cells and 
testedfortheir abilitytoassimilate[35S]cysteine 
and methionine or [3sS]sulfate. 
(A) Schematic diagram of the peptide fusion 
constructs. 
(6) Incorporation of [%]cysteine and methio- 
nine by the fusion proteins. Lane A, superna- 
tant of cells transfected with CDM8 control. 
Lane B, supernatant of cells transfected with 
PSGL-l-immunoglobulin fusion protein. Lane 
C, supernatant of cells transfected with the WT- 
hlgG. Lane D, supernatant of cells transfected 
with Y/F-hlgG. Lane E, supernatant of cells 
transfected with T/A-hlgG. Lane F, supernatant 
of cells transfected with Y/F-T/A-hlgG. 
(C) Incorporation of [%]sulfate. The same con- 
structs were tested as in (B), except that a con- 
trol fusion protein bearing no amino-terminal 
addition (lane B) was included. Lanes C 
through G correspond to B through F in (B). 
3OkD -) 30kD -) 
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may be capable of presenting sLex to E-selectin. These 
findings do not exclude the possibility that specific proteins 
on neutrophils are selectively endowed with SLe”, or pos- 
sess an enhanced capacity to interact with E-selectin by 
virtue of their localization to plasma membrane microvilli. 
Two candidate scaffold proteins that may have superior 
capacity to present sLex to E-selectin are L-selectin on 
human neutrophils (Picker et al., 1991) and ESL-1, a pro- 
tein related to fibroblast growth factor, on a murine granu- 
locytic cell line (Steegmaier et al., 1995). 
In contrast, P-selectin binding cannot be documented 
in cells transfected with fucosyltransferases alone, nor in 
nonhematopoietic cells expressing sLex. A major advance 
in the understanding of P-selectin specificity was the iden- 
tification of PSGL-1, which has a unique ability (among 
human neutrophil surface proteins) tosupport an adhesive 
interaction with P-selectin (Moore et al., 1992, 1994; Sako 
et al., 1993). This interaction was shown to require specific 
glycan modifications that could include sLex. 
The fucosyltransferase employed for the isolation of 
PSGL-1 cDNA by expression cloning, FTIII, is a mixed 
specificity enzyme that synthesizes Lex, sLex, Lea, and 
sLea(Kukowska-Latalloet al., 1990). In thisstudy, we have 
demonstrated that coexpression of PSGL-1 in COS cells 
with the highly specific myeloid lineage enzyme FTVII, 
which synthesizes sLex exclusively (Sasaki et al., 1994; 
Natsuka et al., 1994), is sufficient for acquisition of P-selec- 
tin-binding activity. Thus, it appears that sLex is necessary 
for PSGL-1 cofactor activity and suffices for that activity 
when it is the only exogenous glycosyltransferase coex- 
pressed with PSGL-1 in COS cells. The necessity for other 
posttranslational modifications of PSGL-1 that may be re- 
quired to support P-selectin binding, however, is not ruled 
out by these studies. 
Both L- and P-selectin are known to bind anionic poly- 
mers, L-selectin by mannose8-phosphate polymers, fu- 
coidan, heparin, and related saccharides (Stoolman and 
Rosen, 1983; Stoolman et al., 1984; Norgard-Sumnicht et 
al., 1993; Nelson et al., 1993), and P-selectin by heparin, 
heparan sulfate, dextran sulfate, and fucoidan (Skinner et 
Figure 8. Rolling of HL-60 Cells on P-Selectin- 
lmmunoglobulinChimerasIs Inhibited byChlo- 
rate 
HL-60 cells were infused into a parallel plate 
flow chamber precoated with either P-selectin- 
immunoglobulin chimera or a CD4-immuno- 
globulin chimera control. Cells were subjected 
to a shear stress of 0.75 dynes/cmz. 
(A) Video image of HL-60cells rolling or flowing 
(streaks) over P-selectin-immunoglobulin chi- 
mera. 
(B) HL-60 cells pretreated in sulfate-free me- 
dium with 10 mM sodium chlorate. 
(C) HL-60 cells flowing over coverslip coated 
with CD4-immunoglobulin chimera. 
(D) Tabulation of interacting cells per field from 
eight frames at 15 s intervals of cells shown in 
(A)-(C). Error bars represent SEM. 
al., 1989, 1991; Aruffo et al., 1991), as well as related 
compounds and anionic inositides (Nelson et al., 1993; 
Cecconi et al., 1994). Both selectins interact strongly with 
sulfatides (Watson et al., 1990; lmai et al., 1991; Aruffo 
et al., 1991), 3-sulfated galactosylceramides synthesized 
by neutrophils and present in a vesicular compartment of 
nearly all cells undergoing active division either in vivo or 
in culture (Aruffo et al., 1991; A. Aruffo, W. Kolanus, and 
B. S., unpublished data). Cells with intracellular sulfatide 
pools rapidly assimilate inorganic sulfate into glycolipids 
and excrete them by an as yet uncharacterized mecha- 
nism, leading to the rapid accumulation of sulfated lipids 
in the extracellular space (Aruffo et al., 1991; A. Aruffo, 
W. Kolanus, and B. S., unpublished data). It has previously 
been proposed that neutrophil elaboration of sulfated gly- 
colipids represents a mechanism for detachment of granu- 
locytes from P-selectin once they have traversed the endo- 
thelium and are prepared to migrate into the organ 
parenchyma (Aruffo et al., 1991). However, in studies 
aimed at exploring the role of cell surface sulfatides in 
P-selectin adhesion, it was also found that sodium sele- 
nate, an inhibitor of sulfate assimilation, blocked adhesion 
of a myeloid cell line (HL-60) to P- but not E-selectin immu- 
noglobulin chimeras (Aruffo et al., 1991). We show here 
that asimilar inhibition of P- but not E-selectin binding can 
be demonstrated in COS cells expressing PSGL-1 and a 
sLe”-specific fucosyltransferase. Moreover, we demon- 
strate that HL-60 cells subjected to growth in chlorate, an 
inhibitor of sulfation, have significantly diminished capac- 
ity to attach and roll on P-selectin-coated surfaces under 
conditions of defined flow. 
The sequence determinants that distinguish PSGL-1 as 
a P-selectin counterreceptor appear to be localized within 
a very short segment at the amino terminus of the mole- 
cule, which contains three consensus sites for tyrosine 
sulfation (Sako et al., 1993; Huttner, 1987) and two possi- 
blesitesforo-linkedglycan addition. Thisfinding isconsis- 
tent with reports (Ma et al., 1994; Moore et al., 1995) that 
some monoclonal antibodies that specifically recognize 
PSGL-1 are capable of blocking binding, a result that sup- 
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ports the view that the binding site is relatively localized. 
Elimination of the tyrosines strongly compromises P-selec- 
tin binding and concomitantly blocks the incorporation of 
sulfate into fusion proteins bearing the amino-terminal 
PSGL-1 domain, suggesting that tyrosine sulfate on the 
protein backbone, and sLeX on an O-linked glycan, may 
be jointly sufficient to constitute P-selectin-binding activity. 
Some residual activity can be seen among constructs in 
which the threonines but not tyrosines have been mutated, 
which may reflect the potential utilization of adjacent threo- 
nines of the mucin stalk for glycan presentation. It may also 
be that both tyrosine and glycan sulfations are required for 
P-selectin-binding activity. No sulfation of fusion proteins 
was seen when the tyrosine residues were mutated, but 
the possibility that glycan and tyrosine sulfations are linked 
for that sequence context, or that the sulfation of native 
mucins is independent of tyrosine sulfation, cannot be ex- 
cluded. Unfortunately, metabolic inhibitors capable of dis- 
criminating between tyrosine and glycan sulfations have 
not been described to our knowledge. 
Although studies with N-glycanase have shown that 
N-linked glycans are dispensable for P-selectin-binding 
activity (Moore et al., 1992), the possibility that the threo- 
nines of the active peptide could be replaced by N-linked 
glycan addition sites has not been excluded. Nonetheless, 
the evidence is compelling that both a fucosylated, sialy- 
lated glycan and a motif directing the appearance of sul- 
fated tyrosine are important for binding. 
Where on P-selectin would these structures interact? 
The suggestion that two distinct elements may form a site 
for P-selectin interaction naturally suggests there may be 
discrete locations on P-selectin that bind to different com- 
ponents of the PSGL-1 ligand. A reasonable hypothesis 
might be that the tyrosine sulfates interact with some ele- 
ment of the epidermal growth factor (EGF)-like domain, 
whereas the sLe” interacts with the lectin domain. Some 
support for this hypothesis can be found in the report that 
the L- and P-selectin EGF-like domains are not inter- 
changeable for ligand recognition, suggesting that these 
domains may directly interact with distinct features of the 
selectin ligands (Kansas et al., 1994). Concurrent interac- 
tion of two or more components of PSGL-1 with P-selectin 
lectin domain residues may also take place. A more exotic 
possibility is that the two PSGL-1 components interact with 
a largely contiguous surface of P-selectin in a stereotyped 
temporal sequence, for example, in which the glycan 
forms a rapidly reversible link followed by displacement 
by, or coalescence with, the tyrosine sulfate site. Finally, 
sulfation may effect global changes in amino-terminal do- 
main structure that either influence the subsequent dis- 
position of glycans on the apical residues, or affect the 
conformation of peptide determinants critical for protein- 
protein interaction. 
Experimental Procedures 
Production of Soluble P- and E-Selectin Chimeras 
P- and E-selectin immunoglobulin chimeras were prepared as pre- 
viously described (Aruffo et al., 1991; Walz et al., 1990). The PSGL-1 
cDNA coding sequence was obtained by PCR from an HL-60 cDNA 
library and confirmed by DNA sequencing. The coding segment for the 
mature extracellular, transmembrane, and intracellular domain was 
inserted in an expression vector based on CDM8 that lacks the poly- 
oma virus origin of replication and contains the leader sequence for 
the CD5 antigen positioned just upstream of the coding region for a 
flu peptide (Field et al., 1988) epitope tag (J. Haas and 6. S., unpub- 
lished data). 
Construction of Large Scale PSGL-1 Deletions 
Amino-terminal PSGL-1 deletion constructs were prepared by PCR 
using primers encoding the desired deletion endpoint downstream of 
an Xbal site in frame two (encodes leucine aspartic acid). The resulting 
sequences encoded a polypeptide in which the residues listed below 
immediately followed the aspartic acid (D) of the Xba site: Al 18, Al 28, 
A138, Al48,Al58, A168, G178,A188,Al98,A208, A218,A228,A238, 
A248, A258, and T268 of the PSGL-I precursor. The PCR fragments 
were inserted in the CD5 leader flu tag expression vector used for 
expression of the intact PSGL-1. The flu tag terminates in an Xbal 
site in the frame described above. Sequences at the flu tag junction 
were verified, and expression was confirmed in COS cells by indirect 
immunofluorescence microscopy and flow cytometry. A series of inter- 
nal deletions with an EcoRl site at the site of the deletion in frame 
one (encodes glutamic acid phenylalanine) was also prepared by first 
creating deletion variants with amino termini (residues immediately 
following phenylalanine [F] of the EcoRl site) corresponding to Al 18, 
A128,A138,A148,A158,A168,G178,A188,A198,A208,A218,A228, 
A238, A248, and A258 of the peptide sequence of the precursor. To 
each of these deleted variants was appended a flu-tagged amino- 
terminal PSGL-1 domain ending with an EcoRl site in the glutamic acid 
phenylalanine frame immediately downstream of PSGL-1 precursor 
Al 17. The resulting constructs contain deletions between Al 17 and 
the various endpoints above. 
Mucin Domain Interchanges 
CD34, CD43, and GlyCAM-1 mucins were prepared for addition of the 
PSGL-1 amino-terminal domain by appending an EcoRl site to either 
the mature amino terminus (CD34 or GlyCAM-1), or to the beginning 
of a region of threoninelproline-rich repeats (CD43). As above, the 
EcoRl site was in the frame glutamic acid phenylalanine (frame 1). 
The CD34 sequence began at residue F30 of the precursor, the Gly- 
CAM-l at precursor Ll9, and the CD43 at precursor 1135. To each of 
these was appended the flu-tagged PSGL-1 domain terminating in 
EcoRl as above. The amino terminus and repeat elements of PSGL-1 
were appended to the membrane proximal, transmembrane, and intra- 
cellular domains of CD43 through an EcoRl site in the glutamic acid 
phenylalanine frame positioned immediately upstream of the se- 
quences 5225 of the CD43 precursor. The complementary fragment 
from PSGL-1 corresponded to the amino-terminal residues of the pre- 
cursor up to T267. 
Fine Structure Mapping of the Amino-Terminal Domain 
A similar strategy was employed for the construction of deletions in 
the amino-terminal domain, in which PCR generated deletions were 
formed using primers bearing an Xba site in the leucine aspartic acid 
frame (frame 2). Immediately downstream of the residues encoding 
aspartic acid were the PSGL-1 sequences corresponding to precursor 
R38, E58, P78, and A98. For the definition of the amino-terminal do- 
main, duplex oligonucleotides were synthesized corresponding to the 
residues between 38 and 57 with the indicated sequence changes to 
mutate threonine or tyrosine residues to alanine or phenylalanine. All 
constructs were confirmed by dideoxy sequencing. 
Cell Adhesion Assays 
Transfected cells were detached from culture dishes with 0.5 mM 
EDTA in PBS 48-60 hr after transfection and loaded with 100 pl of 
%r04 (1 mCi/ml; DuPont, Boston, MA) in 0.9% NaCl plus 100 pl of 
medium at 37OC for 1 hr. Loaded cells were washed twice in PBS and 
resuspended in 0.2% BSA, 0.15 M NaCI, 3 mM CaCl>. Variation in 
labeling rate was typically minimal between cells prepared in parallel 
with the same batch of labeled chromate. The labeled cells were incu- 
bated in wellsof 96-well microculture platescoated with affinity-purified 
goat anti-human IgG antibody (100 ul of 20 nglml anti-human IgG Fc 
[heavy chain specific] in PBS) for 2 hr in a humid chamber at room 
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temperature. After washing the plate twice with PBS, additional pro- 
tein-binding sites were blocked by an overnight incubation with 200 
nl of 0.2% BSA in PBS. The plate was washed with PBS four times 
and incubated with 200 ul of fusion protein supernatants for 2 hr. 
Following three PBS washes and one wash in 0.2% BSA, 0.15 M N&I, 
3 mM CaCl*, 2 x lo5 cells/well in 200 nl of 0.2% BSA, 0.15 M NaCI, 
3 mM CaC12 were added and left to bind for 15 min in room temperature 
while the plate rotated on a rotary platform (80 rpm). The plate was 
washed three times by carefully filling the wells with 200 nl of 0.15 M 
NaCI, 3 mM CaClz and then inverting the plate on a pile of paper 
towels. Adherent cells were lysed by the addition of 200 nl of 2% SDS 
and counted in a v-ray spectrometer. 
lmmunofluorescence Analysis 
Cells were prepared for cytometry by incubation with the primary 
monoclonal antibody (typically a I:200 dilution of ascites, or 5 pg/ml 
purified antibody) in PBS containing 3% BSA for 30-45 min. The cells 
were washed twice with PBS and incubated with 2 pglml FITC- 
conjugated affinity-purified antibody to either mouse IgG (12CA5) or 
mouse IgM (CSLEX-1) for 30-45 min in PBS, 3% BSA, and then 
washed twice with PBS, resuspended in 1 ml of 1% formaldehyde in 
PBS prior to analysis. For immunofluorescence microscopy, 
transfected cellswerefixed with 4% freshlydepolymerized paraformat- 
dehyde, washed, exposed to BSA at 3% in PBS for 30 min, and then 
incubated with primary antibody (ascites, 1:250) for 30-45 min, 
washed twice with PBS, and incubated 30-45 min with FITC- 
conjugated affinity-purified antibody to mouse IgG (Cappel) at 2 fig/ 
ml in PBS containing 3% BSA. They were then washed twice with 
PBS and analyzed. 
Metabolic Labeling 
COS cells transfected with expression plasmids encoding immuno- 
globulin chimeraswere trypsinized thedayafter transfection and trans- 
ferred to new plates in complete medium (DMEM with 10% calf serum). 
Prior to labeling, the medium was removed, washed once with PBS, 
and replaced with either cysteine and methionine-free medium for 
labeling with [?S]cysteine and methionine (TransLabel, ICN) or with 
sulfate-free CRCM-30 medium (Sigma) for labeling with sodium 35S0,. 
Serum was not added, and radionuclide was typically present at a 
concentration of 200 j&i/ml. After a labeling interval of 12-16 hr, the 
supernatants were harvested and the fusion proteins collected by ad- 
sorption to goat anti-human IgG agarose (Cappel). Adsorbed proteins 
were subjected to denaturing electrophoresis on 8% polyacrylamide 
gels under reducing conditions. 
Chlorate Inhibition of Adhesion 
COS cells were transfected by DEAE dextran and incubated immedi- 
ately following transfection in DMEM containing 10% calf serum and 
10 mM sodium chlorate. After trypsinization a day after transfection, 
the cells were incubated in fresh dishes in the same medium for 6 hr, 
whereupon the medium was removed, cells were washed with PBS, 
and incubated 18 hrfurther in acustom prepared DMEM medium (Life 
Technologies) lacking sulfate and containing 2% of the usual levels 
of cysteine and methionine with 10% dialyzed fetal bovine serum in 
the presence of 10 mM sodium chlorate (Baeuerle and Huttner, 1986). 
Cells were then harvested for adhesion and immunofluorescence as 
described. Control cells were treated similarly, but were incubated in 
DMEM containing undialyzed serum. 
HL-60 Cell Rolling 
Video images of HL-60 cells rolling through a parallel plate rectangular 
flow chamber (FCS2, Bioptechs, Incorporated, Butler, PA) with a tem- 
perature controlled stage set at 37OC were acquired with an AIMS 
Technology (Bronx, NY) CCD camera mounted on a Zeiss ICM 405 
inverted microscope equipped with a 2.5 x objective. The chamber 
height was 250 pm. Cells were withdrawn through the chamber at a 
defined flow rate with the aid of a Harvard Apparatus (South Natick, 
MA) model I/W 22 syringe pump. Images were analyzed using NIH 
Image. To inhibit sulfation, HL-60 cells were washed once with PBS 
and grown for 18 hr in sulfate-free medium containing 2% of the normal 
levels of cysteine and methionine, 10 mM sodium chlorate, and dia- 
lyzed serum as described above. For each experiment, 106 cells were 
suspended in 1 ml of 0.15 M NaCI, 3 mM CaC12 and drawn through 
the chamber. Glass coverslips were coated with affinity-purified goat 
anti-human IgG antibody at a concentration of 10 pg/ml in 50 mM Tris- 
HCI (pH 9.0) for 2 hr, washed twice with PBS, and blocked overnight 
with 0.2% BSA in PBS. The treated coverslips were then immersed 
in supernatants of COS cells transfected with the appropriate immuno- 
globulin chimera expression plasmids, washed twice with PBS, and 
assembled in the flow chamber. 
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